- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01858350
Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing Sedation
May 16, 2013 updated by: Ambika Mathur, Wayne State University
Comparison of the Effectiveness of Complementary and Alternative Medicine (CAM) Therapies in Pediatric Patients Undergoing Medical Resonance Imagining (MRI) Studies
The investigators conducted a prospective open unblinded clinical four-arm evaluation of Complementary and Alternate Medicine (CAM) interventions on children 1-12 years of age who were undergoing imaging by Medical Resonance Imaging(MRI) and receiving parenteral sedation.
Children were assigned to active music therapy, passive music therapy, distraction therapy, and no intervention; measures included doses and numbers of sedation medications, time of sedation, and salivary levels of the stress hormone cortisol and pro-inflammatory cytokines, before and immediately after the intervention was completed.
The Time Frame for the outcome measures are at the start of the intervention and immediately following the procedure (generally about 150 minutes).
No further follow up was conducted.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
471
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University and Children's Hospital of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children ages 1-12 years undergoing MRI studies
Exclusion Criteria:
- Patients with significant congenital anomalies, genetic syndromes and central nervous system malformations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No intervention
|
|
|
Other: Active Music Therapy
Active Music Therapy: A music therapist plays music to patients for 15 minutes
|
|
|
Other: Passive Music Therapy
Passive Music Therapy: A music therapist plays a compact disc (CD) to patients for 15 minutes
|
|
|
Other: Distraction Therapy
Distraction Therapy: A child life specialist plays with patients for 15 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Need for sedation medications for MRI is reduced
Time Frame: The Time Frame for the outcome measures are at the start of the intervention and immediately following the procedure (average about 150 minutes). No further follow up was conducted.
|
Intervention is performed prior to sedation.
Following sedation, the patient undergoes MRI.
After the MRI is completed, the amount of sedation given to the patient is recorded.
No other follow up is required.
|
The Time Frame for the outcome measures are at the start of the intervention and immediately following the procedure (average about 150 minutes). No further follow up was conducted.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To measure the effect of the interventions on salivary cortisol and inflammatory cytokines
Time Frame: Saliva samples were collected before the intervention and then after the MRI was performed (average about 150 minutes).
|
The aim of this measure was to determine if the interventions changed the levels of salivary cortisol and inflammatory cytokines
|
Saliva samples were collected before the intervention and then after the MRI was performed (average about 150 minutes).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ambika MATHUR, PhD, Wayne State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
May 13, 2013
First Submitted That Met QC Criteria
May 16, 2013
First Posted (Estimate)
May 21, 2013
Study Record Updates
Last Update Posted (Estimate)
May 21, 2013
Last Update Submitted That Met QC Criteria
May 16, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC1AT005699 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Disorders
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Damanhour UniversityMansoura UniversityCompletedNeurological Disorders
-
Pôle Saint HélierCompletedNeurological DisordersFrance
-
University of FloridaNational Science FoundationCompleted
-
National Center for Complementary and Integrative...CompletedNeurological DisordersUnited States
-
South West London and St George's Mental Health...CompletedFunctional Neurological Symptom DisorderUnited Kingdom
-
University of FribourgInsel Gruppe AG, University Hospital BernCompletedFunctional Neurological Symptom Disorder | Neurological Diseases or ConditionsSwitzerland
-
Innodem NeurosciencesTerminatedNeurological DisordersCanada
-
Fondation Ophtalmologique Adolphe de RothschildActive, not recruitingFunctional Neurological DisordersFrance
-
University of Colorado, DenverRecruitingFunctional Neurological DisorderCanada
Clinical Trials on Active Music Therapy
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedAutonomic Nervous System Imbalance | Hypothalamic Pituitary Adrenal Axis SuppressionUnited States
-
Chinese University of Hong KongYangzhou UniversityCompletedAnxiety | Social Connectedness | Emotional Well-BeingChina
-
Mayo ClinicRecruitingSickle Cell DiseaseUnited States
-
University of MalayaCompletedStroke | Dementia | Traumatic Brain InjuryMalaysia
-
Hospices Civils de LyonCompleted
-
BeHnam KhodaRahmiNot yet recruitingStress Regulation and Well-being in Non-clinical ContextsUnited Kingdom
-
University of AarhusDanish Cancer Society; TrygFonden, Denmark; Børnecancerfonden; Ronald McDonalds...Unknown
-
Wilfrid Laurier UniversityRecruiting
-
Sharon Wang-PriceTexas Woman's UniversityRecruitingChronic Low Back PainUnited States
-
Indiana UniversityM.D. Anderson Cancer Center; Children's Mercy Hospital Kansas City; Children's...Completed